Drug intelligence / Profile preview

5D11D4

Development stage
Preclinical
Lead developer
Oxurion
Modality
Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intraperitoneal, Intravitreal, Ophthalmic
01

Overview

5D11D4 is a **mouse IgG1 monoclonal antibody** directed against **placental growth factor** and used as a **preclinical biologic research therapeutic**. It inhibits the **PlGF and neuropilin 1 signaling axis**, a pathway implicated in angiogenesis, tumor growth, inflammatory cell recruitment, and fibrotic wound healing. In the literature provided, 5D11D4 was supplied by **ThromboGenics** and investigated in animal models of **medulloblastoma**, **glaucoma filtration surgery failure**, and **wound healing/scarring**, where it showed antitumor, anti-angiogenic, and anti-fibrotic effects. The available evidence supports that this agent remained an experimental research antibody rather than a clinically developed marketed drug.

Other names
anti-mouse placental growth factor monoclonal antibody
02

Targets

VEGFR-1 (Vascular endothelial growth factor receptor 1)NRP1 (Neuropilin-1)PGF (Placental Growth Factor)

Beyond the preview

Go deeper on 5D11D4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5D11D4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call